Skip to content
buyModerate cluster of 2

Miranda Jayne Toledano bought $17k of ENTX

Chief Executive Officer at Entera Bio Ltd.. 23,952 shares at an average of $0.71, traded Dec 22, 2023, filed Dec 27, 2023.

Conviction score
47
Value
$17k
23,952 shares
Holdings after
110,752
+28% from before
From 52-week low
+18%
low $0.55, close $0.65
From 52-week high
-55%
high $1.44, as of Dec 22, 2023

Score components

  • Role
    CEO
    +25
  • Trade size
    $17k at market
    0
  • Relative to holdings
    Holdings up 28%
    +6
  • Price context
    55% below the 52-week high
    +8
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ENTXOct 9, 2026 · close 2.66
Since filing Dec 27, 2023: +322.2%SPY +68.6% · excess +253.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001178913-23-003971, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 22, 2023POpen-market purchase
Ordinary Shares, par value NIS 0.0000769 per share
+23,952$0.71$17k110,752Dec 27, 2023
Dec 22, 2023POpen-market purchase
Warrants (right to buy)derivative
+23,952$0.13$2,99423,952Dec 27, 2023

Related signals

Other insiders at Entera Bio Ltd. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
51Moderate
ENTXbuy 2
Entera Bio Ltd.
Geno J Germano
director
$26k
20,000 shares
+100%
39Weak
ENTXbuy 2
Entera Bio Ltd.
Sean Ellis
director
$12k
10,000 shares
+6%
53Moderate
ENTXbuy 4
Entera Bio Ltd.
Steven D Rubin
director
$7,450
5,000 shares
+50%
41Moderate
ENTXbuy 4
Entera Bio Ltd.
Sean Ellis
director
$22k
18,000 shares
+11%
46Moderate
ENTXbuy 4
Entera Bio Ltd.
Steven D Rubin
director
$12k
10,000 shares
-
43Moderate
ENTXbuy 4
Entera Bio Ltd.
Geno J Germano
director
$30k
20,000 shares
-
38Weak
ENTXbuy 4
Entera Bio Ltd.
Haya Taitel
director
$11k
7,500 shares
-
25Weak
ENTXbuy
Entera Bio Ltd.
Miranda Jayne Toledano
Chief Executive Officer
$20k
11,000 shares
+3%
30Weak
ENTXbuy
Entera Bio Ltd.
Haya Taitel
director
$9,405
9,500 shares
+37%
29Weak
ENTXbuy
Entera Bio Ltd.
Haya Taitel
director
$5,864
7,615 shares
+42%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.